BCRI (Brazilian Clinical Research Institute) vs a First-in-Human Device CRO (bioaccess®)

BCRI (Brazilian Clinical Research Institute) vs bioaccess®: what BCRI publishes, where it fits in Brazil, and when a medical-device first-in-human specialist in Latin America since 2010 is the better tool.

If you typed BCRI (Brazilian Clinical Research Institute) into a search box, you are probably building a CRO or site shortlist for Brazil. This article uses only what is public about BCRI (ClinicalTrials.gov) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

What BCRI publishes

The Brazilian Clinical Research Institute (BCRI) is an academic research organization in São Paulo. On ClinicalTrials.gov it is the lead sponsor of studies such as the COACTION trial with Bayer (NCT06627530) and the COALIZAO ACTION anticoagulation trial run with leading Brazilian hospitals (NCT04394377).

BCRI vs bioaccess®

Dimension BCRI bioaccess®
Core focus Academic research organization, cardiovascular and pragmatic trials First-in-human and early feasibility studies for medical devices
Geography See provider site Latin America, since 2010
Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
After the trial See provider site Live multi-country sanitary registration and in-country holder service

Where each one fits

If you need an academic research organization for large cardiovascular or pragmatic trials in Brazil, BCRI’s public record matches.

If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including BCRI, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

For the local regulatory path, see CRO in Brazil. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

Ready to compare a proposal? Request a first-in-human study proposal.

Facts from the BCRI public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

← Back to Blog · Contact bioaccess®